Simplex Trading’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Other funds holding ADMA
VCM
VPM
N
Simplex Trading's ADMA Position: Q1 2026 in Review
Simplex Trading opened a new position in ADMA Biologics (ADMA) in Q1 2026: 54,917 shares worth $495K. The stake represents ﹤0.01% of the portfolio and ranks #3277 among its holdings. This is a return to the name: Simplex Trading previously reported a position in ADMA as recently as Q3 2025.
Simplex Trading first reported a position in ADMA in Q3 2018 and has held it in 16 quarters since. The position peaked at $774K in Q3 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.
- Simplex Trading held 54,917 shares of ADMA Biologics worth $495K as of Q1 2026.
- ADMA Biologics was a new Simplex Trading position in Q1 2026.
- ADMA Biologics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3277 holding.
- Simplex Trading first reported a position in ADMA Biologics in Q3 2018 and has held it in 16 quarters since.
- Simplex Trading's ADMA Biologics position peaked at $774K in Q3 2025.
- 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.